IS
IS · IS · IS-EU/1/18/1281/002
Kanjinti
ATC L01FD01
Last synced from Icelandic Medicines Agency (Iceland) on
Identification
ManufacturerAmgen Europe B.V.*
CountryIS (IS)
ATC codeL01FD01
Dispensing—
ReimbursedNo
SourceIcelandic Medicines Agency (Iceland)
Last synced6/9/2026
Packs · 0
No packs registered.
Annotations
No annotations yet.
Raw payload (JSON)
{
"form": "Stofn fyrir innrennslisþykkni, lausn",
"source": "lyfjastofnun",
"atc_raw": "L01FD01",
"marketed": true,
"strength": "420 mg",
"ma_number": "EU/1/18/1281/002",
"substance": "Trastuzumabum INN",
"other_info": null,
"legal_status": "(R) Lyfseðilsskylt\r\n(H) Sjúkrahúsmerkt",
"ma_issued_serial": "43236"
}Related drugs
Other records sharing ATC code L01FD01.
- DKDazublysCurateq Biologics s.r.o.
- ISDazublysCurateq Biologics s.r.o.
- PLDazublysCuraTeQ Biologics s.r.o.
- FIDazublysCurateq Biologics s.r.o.
- FIDazublysCurateq Biologics s.r.o.
- CZDAZUBLYSCuraTeQ Biologics s.r.o., Praha
- BEDazublys 150 mgCuraTeQ Biologics
- NLDazublys 150 mg poeder voor concentraat voor oplossing voor infusie.Curateq Biologics s.r.o.
Access this data programmatically
Query Kanjinti and 610,000+ other drug records through a single REST API — with a last_synced_at provenance stamp on every response. Free tier includes 100 requests/day.